Author:
Ellis Matthew J,Rosen Eric,Dressman Holly,Marks Jeffery
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference21 articles.
1. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial;Ellis;J. Clin. Oncol.,2001
2. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study;Eiermann;Ann. Oncol.,2001
3. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study;Dixon;Clin. Cancer Res.,2000
4. J.M. Dixon, T. Anderson, W.R. Miller, Phase IIb study of neoadjuvant exemestane (EXE) in locally advanced breast cancer, Proc. ASCO 20 (2001) 40b (Abstract #1908).
5. Neoadjuvant endocrine therapy for breast cancer: medical perspectives;Ellis;Clin. Cancer Res.,2001
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献